EDITORIAL POLICY FOR THE WEBSITE

1MG Technologies Private Limited (the "Company") is inter alia engaged in the business of providing technology enabled healthcare services. The Company operates and enables the sale of products vide its website namely www.1mg.com (the “Website”). The Company seeks to that in-house content provided by the Company (“1mg Content”) available on the Website, including without limitation, text, copy, audio, video, photographs, illustrations, graphics and other visuals, is for targeted at general public for informational purposes only and does not constitute professional medical advice, diagnosis, treatment or recommendations of any kind.

  1. 1mg Content is original and is relevant to the general public;
  2. Topics for 1mg Content are selected by our board of qualified experts consisting of certified doctors, pharmacist and medical professionals;
  3. Topics for 1mg are chosen on the basis of current health news, drug alerts, new drug launches, latest medical findings published in peer-reviewed medical journals, such as The Journal of the American Medical Association, The New England Journal of Medicine, The Lancet, Pediatrics, Diabetes Care, and many others;
  4. Editorial Board (as mentioned below) takes into account the latest trending health and wellness topics like dengue, swine flu, seasonal allergies, new vaccines, public awareness trends like Breast Cancer Awareness Month," and "Healthy Heart Month;" as well as emerging health and nutrition trends like health benefits quinoa, use of BGR 34 for managing diabetes, alternative medicine like Ayurveda, homeopathy and much more;
  5. The Company maintains principles of fairness, accuracy, objectivity, and responsible, independent reporting;
  6. The member of the Company has to fully disclose any potential conflict of interest with any sponsor or vendor;
  7. The Company editorial staff holds the responsibility of providing objective, accurate, and balanced accounts of events and issues;
  8. 1mg Editorial Board constitutes of:
    1. Dr Varun Gupta – MBBS, MD (Principal Author)
    2. Dr. Khoobsurat Najma - MBBS (Editor and Senior Author)
    3. Dr.Ila Jain - MBBS, DNB (Author)
    4. Dr. Deepak Soni - BAMS (Author)
    5. Dr. Manju Singh - BHMS (Author)
  9. Questions or comments about the Website or for editorial policy may be directed to the Company at the email address: [email protected]

INDIA’S LARGEST HEALTHCARE PLATFORM

260m+
Visitors
31m+
Orders Delivered
1800+
Cities

Reliable

All products displayed on Tata 1mg are procured from verified and licensed pharmacies. All labs listed on the platform are accredited

Secure

Tata 1mg uses Secure Sockets Layer (SSL) 128-bit encryption and is Payment Card Industry Data Security Standard (PCI DSS) compliant

Affordable

Find affordable medicine substitutes, save up to 50% on health products, up to 80% off on lab tests and free doctor consultations.
LegitScript is a verification and monitoring service for online pharmacies
We are certified "ISO/IEC 27001:2022"
We are certified
"ISO/IEC 27001:2022"